Suppr超能文献

从人肺组织中分离和表征硫酸乙酰肝素。

Isolation and Characterization of Heparan Sulfate from Human Lung Tissues.

机构信息

Institute of Pharmaceutical Sciences, University of Graz, Schubertstraße 1/1, 8010 Graz, Austria.

Antagonis Biotherapeutics GmbH, Strasserhofweg 77a, 8045 Graz, Austria.

出版信息

Molecules. 2021 Sep 10;26(18):5512. doi: 10.3390/molecules26185512.

Abstract

Glycosaminoglycans are a class of linear, highly negatively charged, -linked polysaccharides that are involved in many (patho)physiological processes. In vitro experimental investigations of such processes typically involve porcine-derived heparan sulfate (HS). Structural information about human, particularly organ-specific heparan sulfate, and how it compares with HS from other organisms, is very limited. In this study, heparan sulfate was isolated from human lung tissues derived from five donors and was characterized for their overall size distribution and disaccharide composition. The expression profiles of proteoglycans and HS-modifying enzymes was quantified in order to identify the major core proteins for HS. In addition, the binding affinities of human HS to two chemokines-CXCL8 and CCL2-were investigated, which represent important inflammatory mediators in lung pathologies. Our data revealed that syndecans are the predominant proteoglycan class in human lungs and that the disaccharide composition varies among individuals according to sex, age, and health stage (one of the donor lungs was accidentally discovered to contain a solid tumor). The compositional difference of the five human lung HS preparations affected chemokine binding affinities to various degrees, indicating selective immune cell responses depending on the relative chemokine-glycan affinities. This represents important new insights that could be translated into novel therapeutic concepts for individually treating lung immunological disorders via HS targets.

摘要

糖胺聚糖是一类线性、高度带负电荷的连接多糖,参与许多(病理)生理过程。此类过程的体外实验研究通常涉及猪源硫酸乙酰肝素(HS)。关于人类,特别是器官特异性硫酸乙酰肝素的结构信息以及它与其他生物体 HS 的比较非常有限。在这项研究中,从五名供体的人肺组织中分离出硫酸乙酰肝素,并对其整体大小分布和二糖组成进行了表征。为了鉴定 HS 的主要核心蛋白,还定量了蛋白聚糖和 HS 修饰酶的表达谱。此外,还研究了人 HS 与两种趋化因子(CXCL8 和 CCL2)的结合亲和力,它们是肺病理学中重要的炎症介质。我们的数据表明, syndecans 是人类肺中的主要蛋白聚糖类,并且根据性别、年龄和健康阶段(其中一个供体肺意外地发现含有实体瘤),二糖组成在个体之间存在差异。五种人肺 HS 制剂的组成差异在不同程度上影响了趋化因子的结合亲和力,表明根据相对趋化因子-聚糖亲和力,存在选择性免疫细胞反应。这代表了重要的新见解,可以通过 HS 靶点转化为针对个体治疗肺免疫疾病的新治疗概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213b/8469465/fa4f385191c3/molecules-26-05512-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验